Christopher Hixson

Array ( [id] => 7306182 [patent_doc_number] => 20040116431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use' [patent_app_type] => new [patent_app_number] => 10/730979 [patent_app_country] => US [patent_app_date] => 2003-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41778 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20040116431.pdf [firstpage_image] =>[orig_patent_app_number] => 10730979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1111333 [patent_doc_number] => 06806264 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-10-19 [patent_title] => 'Arylphenyl-substituted cyclic ketoenols' [patent_app_type] => B2 [patent_app_number] => 10/730556 [patent_app_country] => US [patent_app_date] => 2003-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32249 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 465 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/806/06806264.pdf [firstpage_image] =>[orig_patent_app_number] => 10730556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1043770 [patent_doc_number] => 06867203 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-03-15 [patent_title] => 'Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds' [patent_app_type] => utility [patent_app_number] => 10/725212 [patent_app_country] => US [patent_app_date] => 2003-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 103402 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/867/06867203.pdf [firstpage_image] =>[orig_patent_app_number] => 10725212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7310560 [patent_doc_number] => 20040142934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Phthalazine derivatives for treating inflammatory diseases' [patent_app_type] => new [patent_app_number] => 10/723238 [patent_app_country] => US [patent_app_date] => 2003-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33776 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20040142934.pdf [firstpage_image] =>[orig_patent_app_number] => 10723238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 985550 [patent_doc_number] => 06924278 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-02 [patent_title] => 'Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists' [patent_app_type] => utility [patent_app_number] => 10/720021 [patent_app_country] => US [patent_app_date] => 2003-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50129 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/924/06924278.pdf [firstpage_image] =>[orig_patent_app_number] => 10720021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7306343 [patent_doc_number] => 20040116472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Lactone integrin antagonists' [patent_app_type] => new [patent_app_number] => 10/717238 [patent_app_country] => US [patent_app_date] => 2003-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17424 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20040116472.pdf [firstpage_image] =>[orig_patent_app_number] => 10717238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7474060 [patent_doc_number] => 20040122004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Substituted phenylcyclohexanecarboxamides and their use' [patent_app_type] => new [patent_app_number] => 10/715283 [patent_app_country] => US [patent_app_date] => 2003-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19484 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20040122004.pdf [firstpage_image] =>[orig_patent_app_number] => 10715283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7265038 [patent_doc_number] => 20040242574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'QUINAZOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM' [patent_app_type] => new [patent_app_number] => 10/698388 [patent_app_country] => US [patent_app_date] => 2003-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46087 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242574.pdf [firstpage_image] =>[orig_patent_app_number] => 10698388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7435290 [patent_doc_number] => 20040266780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Inhibitors of human phosphatidyl-inositol 3-kinase delta' [patent_app_type] => new [patent_app_number] => 10/697912 [patent_app_country] => US [patent_app_date] => 2003-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 53996 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20040266780.pdf [firstpage_image] =>[orig_patent_app_number] => 10697912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7378181 [patent_doc_number] => 20040220172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'URACIL SUBSTITUTED PHENYL SULFAMOYL CARBOXAMIDES' [patent_app_type] => new [patent_app_number] => 10/684940 [patent_app_country] => US [patent_app_date] => 2003-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24406 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20040220172.pdf [firstpage_image] =>[orig_patent_app_number] => 10684940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7276649 [patent_doc_number] => 20040236100 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Compounds for the treatment of metabolic disorders' [patent_app_type] => new [patent_app_number] => 10/684660 [patent_app_country] => US [patent_app_date] => 2003-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 42743 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20040236100.pdf [firstpage_image] =>[orig_patent_app_number] => 10684660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 993749 [patent_doc_number] => 06916848 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-07-12 [patent_title] => 'Compounds for the treatment of metabolic disorders' [patent_app_type] => utility [patent_app_number] => 10/684730 [patent_app_country] => US [patent_app_date] => 2003-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 41717 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/916/06916848.pdf [firstpage_image] =>[orig_patent_app_number] => 10684730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7367865 [patent_doc_number] => 20040092518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Compounds for the treatment of metabolic disorders' [patent_app_type] => new [patent_app_number] => 10/684735 [patent_app_country] => US [patent_app_date] => 2003-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 42911 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20040092518.pdf [firstpage_image] =>[orig_patent_app_number] => 10684735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7616950 [patent_doc_number] => 06946491 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-09-20 [patent_title] => 'Compounds for the treatment of metabolic disorders' [patent_app_type] => utility [patent_app_number] => 10/685183 [patent_app_country] => US [patent_app_date] => 2003-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 41720 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/946/06946491.pdf [firstpage_image] =>[orig_patent_app_number] => 10685183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7170779 [patent_doc_number] => 20040077896 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Compounds for the treatment of metabolic disorders' [patent_app_type] => new [patent_app_number] => 10/684644 [patent_app_country] => US [patent_app_date] => 2003-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 42672 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20040077896.pdf [firstpage_image] =>[orig_patent_app_number] => 10684644 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7225261 [patent_doc_number] => 20040072836 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Substituted aza-oxindole derivatives' [patent_app_type] => new [patent_app_number] => 10/669400 [patent_app_country] => US [patent_app_date] => 2003-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21878 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072836.pdf [firstpage_image] =>[orig_patent_app_number] => 10669400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1082997 [patent_doc_number] => 06833366 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-12-21 [patent_title] => 'Dihydrostilbene alkanoic acid derivatives' [patent_app_type] => B1 [patent_app_number] => 10/657932 [patent_app_country] => US [patent_app_date] => 2003-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29055 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 802 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/833/06833366.pdf [firstpage_image] =>[orig_patent_app_number] => 10657932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7169615 [patent_doc_number] => 20040077671 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Sorbitol dehydrogenase inhibitors' [patent_app_type] => new [patent_app_number] => 10/645401 [patent_app_country] => US [patent_app_date] => 2003-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 90169 [patent_no_of_claims] => 188 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20040077671.pdf [firstpage_image] =>[orig_patent_app_number] => 10645401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1043769 [patent_doc_number] => 06867202 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-03-15 [patent_title] => 'Treatment of insulin resistance' [patent_app_type] => utility [patent_app_number] => 10/626198 [patent_app_country] => US [patent_app_date] => 2003-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35483 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 1792 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/867/06867202.pdf [firstpage_image] =>[orig_patent_app_number] => 10626198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1134851 [patent_doc_number] => 06784171 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-31 [patent_title] => 'Process for the production of tert-butyl (E)-(6-2-4-(4-fluorophenyl)-6-isopropyl-2-methyl(methylsulfonyl)aminopyrimidin-5-ylvinyl(4R,6S)-2, 2-dimethyl1, 3dioxan-4-yl)acetate' [patent_app_type] => B2 [patent_app_number] => 10/610700 [patent_app_country] => US [patent_app_date] => 2003-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3142 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/784/06784171.pdf [firstpage_image] =>[orig_patent_app_number] => 10610700 [rel_patent_id] =>[rel_patent_doc_number] =>)